
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Coronary Heart Disease (CHD) is the leading cause of death worldwide with 3.8 million men and 3.4 million women dying each year. Cardioprotection refers to the prevention of CHD and the clinical improvement in patients suffering from cardiovascular problems. This book focuses on the role of cardioprotection in surgery and the use of pharmacological therapies such as ACE-inhibitors, statins, and beta-blockers in order tor educe the myocardial injury sustained by the patient and the significant risk of morbidity and mortality. It includes new cardioprotective strategies aimed at improving the clinical outcomes of patients in these settings, as well as current well-established methods for reducing myocardial injury in acute coronary syndrome patients.
This book investigates the clinical strategies and pharmacological interventions necessary to mitigate myocardial injury in patients suffering from coronary heart disease. Authors Derek Hausenloy and Derek Yellon, both established experts in cardiovascular research, synthesize current clinical data to address the high mortality rates associated with heart disease. The text provides a structured framework for applying cardioprotective methods during surgical procedures and acute coronary syndrome management to improve patient survival rates.
What You Will Find
Medical professionals and cardiology students frequently cite this text as a reliable reference for integrating pharmacological cardioprotection into clinical practice. Experts highlight the book's utility in bridging the gap between experimental research and bedside application for cardiovascular patients.
Page Count:
144
Publication Date:
2009-10-18
Publisher:
Oxford University Press
ISBN-10:
019954476X
ISBN-13:
9780199544769
No comments yet. Be the first to share your thoughts!